Type 2 diabetes is exploding globally due to changing diets and sedentary lifestyles. Without accessible, easy-to-administer, and highly effective insulin and GLP-1 regulation medications, patients face catastrophic long-term complications including amputations, blindness, and heart failure.
For decades, the medical community lacked safe, highly effective pharmacological treatments for chronic obesity, relying entirely on difficult behavioral changes or highly invasive bariatric surgeries. This left a massive population without viable medical support for a severe compounding health condition.
Discussion0